Free. Unsubscribe any time.
Immunovant, Inc. (IMVT)
Immunovant, Inc. filed 9 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 12 transactions and 59,751 shares. None carries the SEC's AFF10B5ONE flag; all 9 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-08-28, came 35 days after the one before it (2026-07-24) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 1,500 shares, the same as the 1,500 in the filing before it.
- Its 9 filings on file run from 2025-03-11 to 2026-08-28, and state 4 plan adoption dates, from 2024-12-06 to 2025-12-30.
Trades in Immunovant, Inc. 12
- Fromkin Andrew J. — 2025-03-07 · S · 6,616 shares
- Fromkin Andrew J. — 2025-03-07 · S · 1,384 shares
- Fromkin Andrew J. — 2025-12-01 · S · 19,351 shares
- Fromkin Andrew J. — 2025-12-01 · S · 2,898 shares
- Hughes Douglas J. — 2025-12-01 · S · 13,091 shares
- Hughes Douglas J. — 2025-12-01 · S · 1,909 shares
- Susman Robert Graham — 2026-05-01 · S · 2,502 shares
- Pande Atul — 2026-05-20 · S · 6,000 shares
- Pande Atul — 2026-06-15 · S · 1,500 shares
- Pande Atul — 2026-06-26 · S · 1,500 shares
- Pande Atul — 2026-07-24 · S · 1,500 shares
- Pande Atul — 2026-08-28 · S · 1,500 shares
Adoption dates in Immunovant, Inc. 4
- 2024-12-06 — stated in 2 filings
- 2025-02-14 — stated in 1 filing
- 2025-12-26 — stated in 5 filings
- 2025-12-30 — stated in 1 filing
Results prints in Immunovant, Inc. 0
Trades before a print in Immunovant, Inc. 0
Interval to Immunovant, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 12no later print
Adoption dates Immunovant, Inc. states
- 2024-12-06 in 2 filings
- 2025-02-14 in 1 filing
- 2025-12-26 in 5 filings
- 2025-12-30 in 1 filing
Filing text: “10b5-1 Plan adopted by the reporting person on December 26, 2025”
Sources: SEC EDGAR full-text search and the SEC submissions API.
The address of this record
Immunovant, Inc.’s insider trading plan record — 9 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001764013.